The global market for Small Molecule Drug Discovery was valued at US$ 12400 million in the year 2024 and is projected to reach a revised size of US$ 17260 million by 2031, growing at a CAGR of 4.9% during the forecast period.
The process of small molecule drug discovery can be complex and challenging.Small-molecule drugs are听organic compounds affecting molecular pathways by targeting important proteins, which have a low molecular weight, making them penetrate cells easily. Small-molecule drugs can be developed from leads derived from rational drug design or isolated from natural resources.
The global small molecule drug discovery market refers to the pharmaceutical industry鈥檚 efforts to discover and develop new drugs based on small organic molecules. Small molecule drugs are chemical compounds with relatively low molecular weight that can interact with specific targets in the body to produce a therapeutic effect.
The market for small molecule drug discovery is driven by the increasing demand for novel and effective drugs to treat various diseases, including cancer, cardiovascular disorders, infectious diseases, and neurological disorders. This market encompasses a wide range of activities, including target identification, hit identification and hit-to-lead optimization, lead optimization, preclinical development, and clinical trials.
Several factors contribute to the growth of this market, such as advancements in drug screening technologies, increased understanding of disease mechanisms, and the availability of genomic and proteomic data. Additionally, the rising prevalence of chronic diseases, population aging, and the need for personalized medicine are also driving the demand for small molecule drug discovery.
The market is highly competitive, with numerous pharmaceutical and biotechnology companies, as well as academic research institutions, involved in drug discovery efforts. These organizations invest significant resources in research and development to identify and develop innovative small molecule drugs.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Drug Discovery.
The Small Molecule Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson and Johnson Services, Inc.
Teva Pharmaceutical Industries Ltd
Boehringer Ingelheim International GmbH
Allergan Plc.
Pfizer Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc
GlaxoSmithKline plc.
AstraZeneca
Gilead Sciences, Inc.
Novartis AG
Johnson & Johnson
Roche Holding AG
AstraZeneca PLC
Sanofi
Segment by Type
Target Discovery
Target Validation
Lead Generation
Refinement
Preclinical Development
Others
Segment by Application
Oncology
Central Nervous System
Cardiovascular
Respiratory
Orthopedics
Immunology
Rare Diseases
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Target Discovery
1.2.3 Target Validation
1.2.4 Lead Generation
1.2.5 Refinement
1.2.6 Preclinical Development
1.2.7 Others
1.3 Market by Application
1.3.1 Global Small Molecule Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Central Nervous System
1.3.4 Cardiovascular
1.3.5 Respiratory
1.3.6 Orthopedics
1.3.7 Immunology
1.3.8 Rare Diseases
1.3.9 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Drug Discovery Market Perspective (2020-2031)
2.2 Global Small Molecule Drug Discovery Growth Trends by Region
2.2.1 Global Small Molecule Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule Drug Discovery Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule Drug Discovery Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule Drug Discovery Market Dynamics
2.3.1 Small Molecule Drug Discovery Industry Trends
2.3.2 Small Molecule Drug Discovery Market Drivers
2.3.3 Small Molecule Drug Discovery Market Challenges
2.3.4 Small Molecule Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Drug Discovery Players by Revenue
3.1.1 Global Top Small Molecule Drug Discovery Players by Revenue (2020-2025)
3.1.2 Global Small Molecule Drug Discovery Revenue Market Share by Players (2020-2025)
3.2 Global Small Molecule Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule Drug Discovery Revenue
3.4 Global Small Molecule Drug Discovery Market Concentration Ratio
3.4.1 Global Small Molecule Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug Discovery Revenue in 2024
3.5 Global Key Players of Small Molecule Drug Discovery Head office and Area Served
3.6 Global Key Players of Small Molecule Drug Discovery, Product and Application
3.7 Global Key Players of Small Molecule Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Drug Discovery Breakdown Data by Type
4.1 Global Small Molecule Drug Discovery Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule Drug Discovery Forecasted Market Size by Type (2026-2031)
5 Small Molecule Drug Discovery Breakdown Data by Application
5.1 Global Small Molecule Drug Discovery Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule Drug Discovery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule Drug Discovery Market Size (2020-2031)
6.2 North America Small Molecule Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule Drug Discovery Market Size by Country (2020-2025)
6.4 North America Small Molecule Drug Discovery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Drug Discovery Market Size (2020-2031)
7.2 Europe Small Molecule Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule Drug Discovery Market Size by Country (2020-2025)
7.4 Europe Small Molecule Drug Discovery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drug Discovery Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule Drug Discovery Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule Drug Discovery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Drug Discovery Market Size (2020-2031)
9.2 Latin America Small Molecule Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule Drug Discovery Market Size by Country (2020-2025)
9.4 Latin America Small Molecule Drug Discovery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drug Discovery Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule Drug Discovery Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule Drug Discovery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson Services, Inc.
11.1.1 Johnson and Johnson Services, Inc. Company Details
11.1.2 Johnson and Johnson Services, Inc. Business Overview
11.1.3 Johnson and Johnson Services, Inc. Small Molecule Drug Discovery Introduction
11.1.4 Johnson and Johnson Services, Inc. Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.1.5 Johnson and Johnson Services, Inc. Recent Development
11.2 Teva Pharmaceutical Industries Ltd
11.2.1 Teva Pharmaceutical Industries Ltd Company Details
11.2.2 Teva Pharmaceutical Industries Ltd Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd Small Molecule Drug Discovery Introduction
11.2.4 Teva Pharmaceutical Industries Ltd Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.2.5 Teva Pharmaceutical Industries Ltd Recent Development
11.3 Boehringer Ingelheim International GmbH
11.3.1 Boehringer Ingelheim International GmbH Company Details
11.3.2 Boehringer Ingelheim International GmbH Business Overview
11.3.3 Boehringer Ingelheim International GmbH Small Molecule Drug Discovery Introduction
11.3.4 Boehringer Ingelheim International GmbH Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.3.5 Boehringer Ingelheim International GmbH Recent Development
11.4 Allergan Plc.
11.4.1 Allergan Plc. Company Details
11.4.2 Allergan Plc. Business Overview
11.4.3 Allergan Plc. Small Molecule Drug Discovery Introduction
11.4.4 Allergan Plc. Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.4.5 Allergan Plc. Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Small Molecule Drug Discovery Introduction
11.5.4 Pfizer Inc. Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.5.5 Pfizer Inc. Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Details
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Small Molecule Drug Discovery Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Merck & Co., Inc
11.7.1 Merck & Co., Inc Company Details
11.7.2 Merck & Co., Inc Business Overview
11.7.3 Merck & Co., Inc Small Molecule Drug Discovery Introduction
11.7.4 Merck & Co., Inc Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.7.5 Merck & Co., Inc Recent Development
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Company Details
11.8.2 GlaxoSmithKline plc. Business Overview
11.8.3 GlaxoSmithKline plc. Small Molecule Drug Discovery Introduction
11.8.4 GlaxoSmithKline plc. Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.8.5 GlaxoSmithKline plc. Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Small Molecule Drug Discovery Introduction
11.9.4 AstraZeneca Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.9.5 AstraZeneca Recent Development
11.10 Gilead Sciences, Inc.
11.10.1 Gilead Sciences, Inc. Company Details
11.10.2 Gilead Sciences, Inc. Business Overview
11.10.3 Gilead Sciences, Inc. Small Molecule Drug Discovery Introduction
11.10.4 Gilead Sciences, Inc. Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.10.5 Gilead Sciences, Inc. Recent Development
11.11 Novartis AG
11.11.1 Novartis AG Company Details
11.11.2 Novartis AG Business Overview
11.11.3 Novartis AG Small Molecule Drug Discovery Introduction
11.11.4 Novartis AG Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.11.5 Novartis AG Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Small Molecule Drug Discovery Introduction
11.12.4 Johnson & Johnson Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.12.5 Johnson & Johnson Recent Development
11.13 Roche Holding AG
11.13.1 Roche Holding AG Company Details
11.13.2 Roche Holding AG Business Overview
11.13.3 Roche Holding AG Small Molecule Drug Discovery Introduction
11.13.4 Roche Holding AG Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.13.5 Roche Holding AG Recent Development
11.14 AstraZeneca PLC
11.14.1 AstraZeneca PLC Company Details
11.14.2 AstraZeneca PLC Business Overview
11.14.3 AstraZeneca PLC Small Molecule Drug Discovery Introduction
11.14.4 AstraZeneca PLC Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.14.5 AstraZeneca PLC Recent Development
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Small Molecule Drug Discovery Introduction
11.15.4 Sanofi Revenue in Small Molecule Drug Discovery Business (2020-2025)
11.15.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Johnson and Johnson Services, Inc.
Teva Pharmaceutical Industries Ltd
Boehringer Ingelheim International GmbH
Allergan Plc.
Pfizer Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc
GlaxoSmithKline plc.
AstraZeneca
Gilead Sciences, Inc.
Novartis AG
Johnson & Johnson
Roche Holding AG
AstraZeneca PLC
Sanofi
听
听
*If Applicable.
